Is 18F-DOPA a valid cardiac sympathetic neuroimaging agent?

被引:0
作者
David S. Goldstein
Courtney Holmes
机构
[1] National Institute of Neurological Disorders and Stroke,Autonomic Medicine Section, Clinical Neurosciences Program, Division of Intramural Research
[2] National Institutes of Health,undefined
来源
Clinical Autonomic Research | 2022年 / 32卷
关键词
Fluorodopa; Fluorodopamine; Sympathetic nervous system; Positron emission tomography; Neuroimaging;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:445 / 453
页数:8
相关论文
共 139 条
  • [1] Brown WD(1998)Fluorine-18-fluoro- J Nucl Med 39 1884-1891
  • [2] Oakes TR(2020)-DOPA dosimetry with carbidopa pretreatment Rev Esp Med Nucl Imagen Mol (Engl Ed) 39 279-283
  • [3] DeJesus OT(1996)The role of (18)F-DOPA PET/CT in the diagnosis of the congenital focal form of hyperinsulinism in children Circulation 93 1667-1676
  • [4] Taylor MD(1989)Cardiac sympathetic nerve function in congestive heart failure Am J Physiol 256 E284-E287
  • [5] Roberts AD(2011)Dopa, norepinephrine, and dopamine in rat tissues: no effect of sympathectomy on muscle dopa Clin Auton Res 21 69-72
  • [6] Nickles RJ(2003)Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome Lancet Neurol 2 669-676
  • [7] Holden JE(1993)Dysautonomia in Parkinson's disease: neurocardiological abnormalities J Am Coll Cardiol 22 1961-1971
  • [8] Chroustova D(2008)Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans Parkinsonism Relat Disord 14 600-607
  • [9] Trnka J(2018)Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy Parkinsonism Relat Disord 52 90-93
  • [10] Pudlac A(2011)Cardiac sympathetic denervation predicts PD in at-risk individuals J Neurol Sci 310 118-122